Theradiag Balance Sheet Health
Financial Health criteria checks 4/6
Theradiag has a total shareholder equity of €9.3M and total debt of €1.6M, which brings its debt-to-equity ratio to 17.1%. Its total assets and total liabilities are €14.5M and €5.2M respectively. Theradiag's EBIT is €686.1K making its interest coverage ratio 8.3. It has cash and short-term investments of €5.7M.
Key information
17.1%
Debt to equity ratio
€1.59m
Debt
| Interest coverage ratio | 8.3x |
| Cash | €5.67m |
| Equity | €9.30m |
| Total liabilities | €5.17m |
| Total assets | €14.47m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: ALTER's short term assets (€10.6M) exceed its short term liabilities (€2.5M).
Long Term Liabilities: ALTER's short term assets (€10.6M) exceed its long term liabilities (€2.7M).
Debt to Equity History and Analysis
Debt Level: ALTER has more cash than its total debt.
Reducing Debt: ALTER's debt to equity ratio has increased from 0.9% to 17.1% over the past 5 years.
Debt Coverage: Insufficient data to determine if ALTER's debt is well covered by operating cash flow.
Interest Coverage: ALTER's interest payments on its debt are well covered by EBIT (8.3x coverage).